| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH4 MYH8 MYO9A DHX38 MCM5 ABCA9 ABCA8 DHX15 ATP11B DNAH6 DNAH9 RAD17 PMS1 ATP8B3 SMCHD1 MSH3 DNAH12 ENTPD1 MACF1 DNAH11 | 5.42e-06 | 614 | 240 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 MYH8 DHX38 MCM5 ABCA9 ABCA8 DHX15 ATP11B DNAH6 DNAH9 RAD17 PMS1 ATP8B3 SMCHD1 DNAH12 ENTPD1 MACF1 DNAH11 | 7.01e-06 | 441 | 240 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.29e-05 | 118 | 240 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | kinase activity | DCAF1 EPHA6 TRPM7 DGKA PFKFB2 NME9 MAP3K4 RPS6KC1 MAST4 ALDH18A1 CCL2 UCK2 KDR TAF1 PPIP5K2 MMD2 WNK2 FLT1 GRK4 TEC CERT1 PRKDC EPHA3 EPHA5 | 1.81e-05 | 764 | 240 | 24 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | DCAF1 EPHA6 TRPM7 DGKA PFKFB2 NME9 MAP3K4 RPS6KC1 MAST4 ALDH18A1 CCL2 UCK2 KDR TAF1 PPIP5K2 MMD2 WNK2 FLT1 POLE GRK4 OAS1 TEC CERT1 POLR3A PRKDC EPHA3 EPHA5 | 2.50e-05 | 938 | 240 | 27 | GO:0016772 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.46e-05 | 18 | 240 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 8.74e-05 | 38 | 240 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 9.18e-05 | 8 | 240 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 9.18e-05 | 8 | 240 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 1.44e-04 | 2 | 240 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 1.44e-04 | 2 | 240 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 1.44e-04 | 2 | 240 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 1.44e-04 | 2 | 240 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH4 MYH8 DHX38 MCM5 ABCA9 ABCA8 DHX15 ATP11B GNAI3 DNAH6 DNAH9 RAD17 PMS1 ATP8B3 DRG2 SMCHD1 RGS14 EEF2 DNAH12 ENTPD1 MACF1 DNAH11 | 1.77e-04 | 775 | 240 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH4 MYH8 DHX38 MCM5 ABCA9 ABCA8 DHX15 ATP11B GNAI3 DNAH6 DNAH9 RAD17 PMS1 ATP8B3 DRG2 CILP SMCHD1 RGS14 EEF2 DNAH12 ENTPD1 MACF1 DNAH11 | 2.09e-04 | 839 | 240 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH4 MYH8 DHX38 MCM5 ABCA9 ABCA8 DHX15 ATP11B GNAI3 DNAH6 DNAH9 RAD17 PMS1 ATP8B3 DRG2 CILP SMCHD1 RGS14 EEF2 DNAH12 ENTPD1 MACF1 DNAH11 | 2.13e-04 | 840 | 240 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH4 MYH8 DHX38 MCM5 ABCA9 ABCA8 DHX15 ATP11B GNAI3 DNAH6 DNAH9 RAD17 PMS1 ATP8B3 DRG2 CILP SMCHD1 RGS14 EEF2 DNAH12 ENTPD1 MACF1 DNAH11 | 2.13e-04 | 840 | 240 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 2.63e-04 | 11 | 240 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.32e-04 | 28 | 240 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | DCAF1 EPHA6 TRPM7 DGKA PFKFB2 MAP3K4 RPS6KC1 MAST4 CCL2 UCK2 KDR TAF1 MMD2 WNK2 FLT1 GRK4 TEC PRKDC EPHA3 EPHA5 | 3.80e-04 | 709 | 240 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 4.28e-04 | 3 | 240 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 7.01e-04 | 15 | 240 | 3 | GO:0005005 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 7.01e-04 | 15 | 240 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 8.50e-04 | 4 | 240 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 8.50e-04 | 4 | 240 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.84e-04 | 37 | 240 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | protein kinase activity | DCAF1 EPHA6 TRPM7 MAP3K4 RPS6KC1 MAST4 CCL2 KDR TAF1 MMD2 WNK2 FLT1 GRK4 TEC PRKDC EPHA3 EPHA5 | 9.91e-04 | 600 | 240 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.11e-03 | 65 | 240 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 1.40e-03 | 5 | 240 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 1.40e-03 | 5 | 240 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 1.40e-03 | 5 | 240 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 1.40e-03 | 5 | 240 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 1.40e-03 | 5 | 240 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.44e-03 | 19 | 240 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.76e-03 | 227 | 240 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.87e-03 | 229 | 240 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | CMTR1 DHX38 MCM5 SLFN14 DUS1L DHX15 DNMT1 RAD17 SMG6 PMS1 MRM2 POLE RPP30 MSH3 POLR3A TRMT44 SND1 | 2.14e-03 | 645 | 240 | 17 | GO:0140640 |
| GeneOntologyCellularComponent | muscle myosin complex | 2.86e-05 | 16 | 242 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 1.83e-04 | 25 | 242 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | SAGA complex | 1.83e-04 | 25 | 242 | 4 | GO:0000124 | |
| GeneOntologyCellularComponent | myosin II complex | 2.88e-04 | 28 | 242 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | dynein complex | 3.97e-04 | 54 | 242 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | ATAC complex | 5.08e-04 | 14 | 242 | 3 | GO:0140672 | |
| GeneOntologyCellularComponent | myosin complex | 6.00e-04 | 59 | 242 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | sarcomere | 6.78e-04 | 249 | 242 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | SAGA-type complex | 1.05e-03 | 39 | 242 | 4 | GO:0070461 | |
| GeneOntologyCellularComponent | transcription factor TFTC complex | 1.10e-03 | 18 | 242 | 3 | GO:0033276 | |
| Domain | Bromodomain_CS | 1.81e-05 | 26 | 241 | 5 | IPR018359 | |
| Domain | ATPase_dyneun-rel_AAA | 2.45e-05 | 14 | 241 | 4 | IPR011704 | |
| Domain | AAA_8 | 2.45e-05 | 14 | 241 | 4 | PF12780 | |
| Domain | AAA_5 | 2.45e-05 | 14 | 241 | 4 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.45e-05 | 14 | 241 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.45e-05 | 14 | 241 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.45e-05 | 14 | 241 | 4 | PF08393 | |
| Domain | NPIP | 2.45e-05 | 14 | 241 | 4 | IPR009443 | |
| Domain | Myosin_N | 3.30e-05 | 15 | 241 | 4 | IPR004009 | |
| Domain | DHC_fam | 3.30e-05 | 15 | 241 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 3.30e-05 | 15 | 241 | 4 | PF03028 | |
| Domain | Myosin_N | 3.30e-05 | 15 | 241 | 4 | PF02736 | |
| Domain | Dynein_heavy_dom | 3.30e-05 | 15 | 241 | 4 | IPR004273 | |
| Domain | Myosin_tail_1 | 7.18e-05 | 18 | 241 | 4 | PF01576 | |
| Domain | Myosin_tail | 7.18e-05 | 18 | 241 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 9.00e-05 | 19 | 241 | 4 | IPR027401 | |
| Domain | - | 9.00e-05 | 19 | 241 | 4 | 4.10.270.10 | |
| Domain | BROMODOMAIN_1 | 1.07e-04 | 37 | 241 | 5 | PS00633 | |
| Domain | MYOSIN_MOTOR | 1.22e-04 | 38 | 241 | 5 | PS51456 | |
| Domain | Myosin_head_motor_dom | 1.22e-04 | 38 | 241 | 5 | IPR001609 | |
| Domain | Bromodomain | 1.22e-04 | 38 | 241 | 5 | PF00439 | |
| Domain | Myosin_head | 1.22e-04 | 38 | 241 | 5 | PF00063 | |
| Domain | MYSc | 1.22e-04 | 38 | 241 | 5 | SM00242 | |
| Domain | PCAF_N | 1.66e-04 | 2 | 241 | 2 | PF06466 | |
| Domain | Hist_acetylase_PCAF | 1.66e-04 | 2 | 241 | 2 | IPR016376 | |
| Domain | LYZL1/LYZL2 | 1.66e-04 | 2 | 241 | 2 | IPR030057 | |
| Domain | PCAF_N | 1.66e-04 | 2 | 241 | 2 | IPR009464 | |
| Domain | BROMODOMAIN_2 | 1.76e-04 | 41 | 241 | 5 | PS50014 | |
| Domain | Bromodomain | 1.98e-04 | 42 | 241 | 5 | IPR001487 | |
| Domain | - | 1.98e-04 | 42 | 241 | 5 | 1.20.920.10 | |
| Domain | BROMO | 1.98e-04 | 42 | 241 | 5 | SM00297 | |
| Domain | Ephrin_rec_like | 2.76e-04 | 25 | 241 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 2.76e-04 | 25 | 241 | 4 | IPR011641 | |
| Domain | AAA+_ATPase | 5.71e-04 | 144 | 241 | 8 | IPR003593 | |
| Domain | AAA | 5.71e-04 | 144 | 241 | 8 | SM00382 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 6.95e-04 | 14 | 241 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 6.95e-04 | 14 | 241 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 6.95e-04 | 14 | 241 | 3 | IPR001426 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 6.95e-04 | 14 | 241 | 3 | IPR001090 | |
| Domain | Eph_TM | 6.95e-04 | 14 | 241 | 3 | IPR027936 | |
| Domain | MT | 6.95e-04 | 14 | 241 | 3 | PF12777 | |
| Domain | Dynein_HC_stalk | 6.95e-04 | 14 | 241 | 3 | IPR024743 | |
| Domain | EphA2_TM | 6.95e-04 | 14 | 241 | 3 | PF14575 | |
| Domain | EPH_lbd | 6.95e-04 | 14 | 241 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 6.95e-04 | 14 | 241 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 6.95e-04 | 14 | 241 | 3 | IPR016257 | |
| Domain | EPH_LBD | 6.95e-04 | 14 | 241 | 3 | PS51550 | |
| Domain | - | 9.44e-04 | 120 | 241 | 7 | 3.40.50.150 | |
| Domain | Tyr_kinase_cat_dom | 9.73e-04 | 88 | 241 | 6 | IPR020635 | |
| Domain | TyrKc | 9.73e-04 | 88 | 241 | 6 | SM00219 | |
| Domain | SAM-dependent_MTases | 1.04e-03 | 122 | 241 | 7 | IPR029063 | |
| Domain | CYCLIN | 1.41e-03 | 38 | 241 | 4 | SM00385 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH4 MYH8 MYO9A DHX38 MCM5 PFKFB2 SLFN14 ABCA9 ABCA8 DHX15 UCK2 GNAI3 DNAH6 DNAH9 RAD17 DRG2 MSH3 EEF2 DNAH12 DNAH11 | 1.51e-03 | 848 | 241 | 22 | IPR027417 |
| Domain | PROTEIN_KINASE_TYR | 1.61e-03 | 97 | 241 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.61e-03 | 97 | 241 | 6 | IPR008266 | |
| Domain | ACP_DOMAIN | 1.62e-03 | 5 | 241 | 2 | PS50075 | |
| Domain | - | 1.62e-03 | 5 | 241 | 2 | 3.40.50.920 | |
| Domain | FtsJ | 1.62e-03 | 5 | 241 | 2 | PF01728 | |
| Domain | Transketolase_C | 1.62e-03 | 5 | 241 | 2 | IPR033248 | |
| Domain | Transketolase_fam | 1.62e-03 | 5 | 241 | 2 | IPR033247 | |
| Domain | - | 1.62e-03 | 5 | 241 | 2 | 1.10.1200.10 | |
| Domain | Transketo_C/PFOR_II | 1.62e-03 | 5 | 241 | 2 | IPR009014 | |
| Domain | rRNA_MeTrfase_FtsJ_dom | 1.62e-03 | 5 | 241 | 2 | IPR002877 | |
| Domain | Transketolase_C | 1.62e-03 | 5 | 241 | 2 | PF02780 | |
| Domain | PP-binding | 1.62e-03 | 5 | 241 | 2 | PF00550 | |
| Domain | - | 1.72e-03 | 40 | 241 | 4 | 1.10.472.10 | |
| Pubmed | MYH1 MYH2 MYH4 AHCYL1 MYH8 DGKA MCM5 TKTL1 KAT2A RPS6KC1 FASN PKHD1 KDR GNAI3 PLEC DMD PPIP5K2 METTL25 DNAH6 PLXNA2 NSD2 SMCHD1 UBR4 DUOX2 INSYN2A RGS14 EEF2 TIMM21 DOK4 SND1 CAPRIN2 MACF1 PRKDC PSPC1 RAI1 | 3.01e-10 | 1442 | 249 | 35 | 35575683 | |
| Pubmed | CAND1 DHX38 MCM5 KAT2A DHX15 FASN IRF2BPL TAF1 PLEC TAF12 TADA3 DNMT1 NSD2 POLE SMCHD1 UBR4 MSH3 POLR3A CCNA2 EEF2 SND1 PEBP1 PRIM2 WDR82 SMS PRKDC PSPC1 | 5.65e-09 | 1014 | 249 | 27 | 32416067 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.28e-08 | 5 | 249 | 4 | 12919077 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.28e-08 | 5 | 249 | 4 | 3829126 | |
| Pubmed | 1.28e-08 | 5 | 249 | 4 | 6196357 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 AHCYL1 CAND1 CASP14 GAPDH MYO9A DHX38 MCM5 DHX15 FASN ALDH18A1 PLEC FHL2 DNMT1 DNAJC13 POLE SMCHD1 UBR4 RPP30 MSH3 KRR1 POLR3A EEF2 ARRB2 SND1 WDR6 PRIM2 MACF1 WDR82 PRKDC DCTN4 | 1.31e-08 | 1353 | 249 | 31 | 29467282 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 MYH2 MYH4 AHCYL1 CAND1 CASP14 DHX38 MCM5 KAT2A NDUFS2 SCML2 GLDC KLHL42 ALDH18A1 PLEC TADA3 DNMT1 RAD17 KRR1 CERT1 POLR3A CCNA2 SND1 RRN3 PRIM2 KDM4A | 1.97e-08 | 1005 | 249 | 26 | 19615732 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP RAPGEF6 MCM5 KAT2A CIC RYR1 DUS1L LIME1 FASN TULP4 PLEC ZNF614 WNK2 SMG6 LAT2 NSD2 POLE UBR4 DOK4 SND1 IL17RE PIGW PRKDC HAS3 PRDM16 ADAT1 RAI1 | 3.34e-08 | 1105 | 249 | 27 | 35748872 |
| Pubmed | 3.80e-08 | 6 | 249 | 4 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.80e-08 | 6 | 249 | 4 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.80e-08 | 6 | 249 | 4 | 10588881 | |
| Pubmed | DCAF1 ZNF219 FASTKD5 BCKDHB KAT2A ABCA8 LARP4B KAT2B TC2N BRDT BRPF1 UCK2 ADAM17 TAF1 TAF12 TADA3 CCNL2 NSD2 ZFHX4 TIMM21 WDR6 CAPRIN2 TCF25 MACF1 OSMR PRDM16 RAI1 | 4.09e-08 | 1116 | 249 | 27 | 31753913 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TPP2 DHX38 MCM5 MAP3K4 FASN GNAI3 FHL2 DNMT1 DRG2 POLE UBR4 RPP30 MSH3 POLR3A TIMM21 SND1 PRIM2 WDR82 SMS PRKDC DCTN4 | 4.65e-08 | 704 | 249 | 21 | 29955894 |
| Pubmed | TPP2 DHX38 MCM5 DHX15 LARP4B FASN ALDH18A1 PLEC DNMT1 NSD2 POLE SMCHD1 UBR4 USP24 KRR1 SND1 WDR6 MACF1 PRKDC RAI1 | 6.42e-08 | 653 | 249 | 20 | 22586326 | |
| Pubmed | NR2C2 RAPGEF6 CIC ZNF462 FASN NR0B1 TAF1 PLEC DNAJC13 DRG2 UBR4 USP24 ZDBF2 ARRB2 ZFHX4 WDR6 | 7.12e-08 | 418 | 249 | 16 | 34709266 | |
| Pubmed | 8.83e-08 | 7 | 249 | 4 | 35210422 | ||
| Pubmed | 8.83e-08 | 7 | 249 | 4 | 16819597 | ||
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 23081704 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 3.63e-07 | 3 | 249 | 3 | 26059207 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 18496682 | ||
| Pubmed | Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle. | 3.63e-07 | 3 | 249 | 3 | 15013776 | |
| Pubmed | AHCYL1 MYH8 CYP2C9 CAND1 EPHA6 TRPM7 DHX38 FASTKD5 KAT2A NDUFS2 FASN NR0B1 ALDH18A1 CCL11 TADA3 SLC23A1 CCNL2 MRM2 RBL2 UBR4 ZDBF2 CCNA2 TRMT44 LRRC20 WDR82 KDM4A SMS CYB5R4 | 3.72e-07 | 1327 | 249 | 28 | 32694731 | |
| Pubmed | 4.31e-07 | 22 | 249 | 5 | 24301466 | ||
| Pubmed | 8.14e-07 | 11 | 249 | 4 | 8136524 | ||
| Pubmed | Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy. | 1.44e-06 | 4 | 249 | 3 | 24340040 | |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 1.44e-06 | 4 | 249 | 3 | 18055785 | |
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 20357587 | ||
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 1985022 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.44e-06 | 4 | 249 | 3 | 18417546 | |
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 10388558 | ||
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 11023856 | ||
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 24527758 | ||
| Pubmed | The transcriptional co-activator PCAF regulates cdk2 activity. | 1.44e-06 | 4 | 249 | 3 | 19773423 | |
| Pubmed | Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. | 1.44e-06 | 4 | 249 | 3 | 14612453 | |
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.44e-06 | 4 | 249 | 3 | 11029314 | |
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 28990182 | ||
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 19593158 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.74e-06 | 13 | 249 | 4 | 8404542 | |
| Pubmed | 2.43e-06 | 14 | 249 | 4 | 27184118 | ||
| Pubmed | GAPDH MCM5 PFKFB2 DHX15 LARP4B FASN ATXN2 ALDH18A1 PLEC UBR4 KRR1 EEF2 SND1 WDR82 PRKDC PSPC1 | 2.74e-06 | 551 | 249 | 16 | 34728620 | |
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 20705734 | ||
| Pubmed | Gcn5 and PCAF regulate PPARγ and Prdm16 expression to facilitate brown adipogenesis. | 3.59e-06 | 5 | 249 | 3 | 25071153 | |
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 19106084 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 21071160 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 21596751 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 19029318 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 19414633 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 17418993 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 25387128 | ||
| Pubmed | Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study. | 3.59e-06 | 5 | 249 | 3 | 19926050 | |
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 12900870 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 3.59e-06 | 5 | 249 | 3 | 30737693 | |
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 25552922 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 19823875 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 18089809 | ||
| Pubmed | 3.64e-06 | 33 | 249 | 5 | 11564863 | ||
| Pubmed | TPP2 NR2C2 CAND1 GAPDH MCM5 KAT2A CIC DHX15 FASN ATXN2 TADA3 DNMT1 SMCHD1 RPP30 AASDH EEF2 SND1 PEBP1 WDR82 SMS PRKDC PSPC1 RAI1 | 5.27e-06 | 1103 | 249 | 23 | 34189442 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CMTR1 GIT2 DHX15 LARP4B SCML2 CEP78 ATXN2 BRPF1 PLEC TADA3 DNAJC13 MAP7D3 RPP30 SND1 WDR6 RRN3 MACF1 WDR82 | 5.65e-06 | 724 | 249 | 18 | 36232890 |
| Pubmed | Histone-like TAFs within the PCAF histone acetylase complex. | 5.67e-06 | 17 | 249 | 4 | 9674425 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPP2 AHCYL1 CAND1 GAPDH DHX38 MCM5 DHX15 FASN UBE2V1 IRF2BPL GNAI3 PLEC FHL2 DRG2 UBR4 RPP30 USP24 CERT1 DENR DERA EEF2 SND1 PRIM2 MACF1 SMS PRKDC DCTN4 | 6.68e-06 | 1455 | 249 | 27 | 22863883 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CAND1 GAPDH RYR1 DHX15 FASN CLEC4F UBE2V1 BRPF1 ALDH18A1 PLEC UBR4 GSTM4 EEF2 SND1 PEBP1 MACF1 SMS PRKDC PGM2 | 6.71e-06 | 807 | 249 | 19 | 30575818 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 MYH4 GAPDH DGKA PARVG DSCAML1 NDUFS2 OR52N1 RYR1 RPS6KC1 NEUROD2 PKHD1 ALDH18A1 MROH9 UBR4 PIGW PRKDC RAI1 | 7.06e-06 | 736 | 249 | 18 | 29676528 |
| Pubmed | 7.14e-06 | 6 | 249 | 3 | 17900275 | ||
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 7.14e-06 | 6 | 249 | 3 | 17635176 | |
| Pubmed | 7.14e-06 | 6 | 249 | 3 | 18231117 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 7.14e-06 | 6 | 249 | 3 | 17559643 | |
| Pubmed | 7.14e-06 | 6 | 249 | 3 | 20417199 | ||
| Pubmed | 7.14e-06 | 6 | 249 | 3 | 15996548 | ||
| Pubmed | 7.14e-06 | 6 | 249 | 3 | 9398194 | ||
| Pubmed | 7.14e-06 | 6 | 249 | 3 | 16401082 | ||
| Pubmed | 8.53e-06 | 39 | 249 | 5 | 38690566 | ||
| Pubmed | 9.13e-06 | 19 | 249 | 4 | 16396910 | ||
| Pubmed | DAB2IP AHCYL1 CAND1 GAPDH MCM5 GIT2 SLFN14 IRF2BPL GNAI3 DNMT1 PMS1 EEF2 WDR6 | 9.72e-06 | 411 | 249 | 13 | 36652389 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NR2C2 AHCYL1 GAPDH ZNF462 KAT2B TAF1 TAF12 MSH3 ZFHX4 WDR6 PRDM16 RAI1 | 9.92e-06 | 351 | 249 | 12 | 38297188 |
| Pubmed | 1.11e-05 | 192 | 249 | 9 | 20602615 | ||
| Pubmed | 1.11e-05 | 105 | 249 | 7 | 24667918 | ||
| Pubmed | Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II. | 1.14e-05 | 20 | 249 | 4 | 9603525 | |
| Pubmed | 1.14e-05 | 20 | 249 | 4 | 10373431 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | CAND1 CMTR1 GAPDH DHX38 DHX15 FASN ALDH18A1 PMS1 SMCHD1 MSH3 EEF2 PRKDC | 1.17e-05 | 357 | 249 | 12 | 37059091 |
| Pubmed | Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. | 1.24e-05 | 7 | 249 | 3 | 19219744 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.24e-05 | 7 | 249 | 3 | 29758057 | |
| Pubmed | MYH1 MYH2 MYH4 MYH8 CASP14 GAPDH MYO9A MCM5 DHX15 FASN BRDT PLEC DMD FHL2 UBR4 EEF2 SND1 MACF1 PRKDC | 1.26e-05 | 844 | 249 | 19 | 25963833 | |
| Pubmed | CAND1 GAPDH DHX38 DGKA MCM5 ITGA4 LARP4B FASN ATP11B ATXN2 ADAM17 GNAI3 DNAJC13 DRG2 MAP7D3 UBR4 MSH3 KRR1 POLR3A EEF2 ENTPD1 PRKDC CTSW | 1.32e-05 | 1168 | 249 | 23 | 19946888 | |
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 1.45e-05 | 73 | 249 | 6 | 32347575 | |
| Pubmed | CMTR1 EXPH5 DHX38 ABCA8 ZNF462 LARP4B TULP4 SPON1 IRF2BPL TRAPPC8 MACF1 PRDM16 FGD6 REXO1L1P | 1.48e-05 | 493 | 249 | 14 | 15368895 | |
| Pubmed | 1.69e-05 | 75 | 249 | 6 | 25593309 | ||
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 1.72e-05 | 155 | 249 | 8 | 22673621 | |
| Pubmed | Mistargeting hippocampal axons by expression of a truncated Eph receptor. | 1.98e-05 | 8 | 249 | 3 | 12124402 | |
| Pubmed | 1.98e-05 | 8 | 249 | 3 | 18356043 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 1.98e-05 | 8 | 249 | 3 | 14667415 | |
| Pubmed | 1.98e-05 | 8 | 249 | 3 | 26993635 | ||
| Pubmed | 1.98e-05 | 8 | 249 | 3 | 3864153 | ||
| Pubmed | 1.98e-05 | 8 | 249 | 3 | 20147896 | ||
| Pubmed | The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. | 1.98e-05 | 8 | 249 | 3 | 9806910 | |
| Pubmed | 1.98e-05 | 8 | 249 | 3 | 33667029 | ||
| Pubmed | 1.98e-05 | 8 | 249 | 3 | 36200826 | ||
| Pubmed | ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. | 1.98e-05 | 8 | 249 | 3 | 19593168 | |
| Pubmed | AHCYL1 CASP14 GAPDH MCM5 NDUFS2 DHX15 LARP4B KAT2B FASN ATXN2 DNMT1 SMCHD1 RPP30 TEC KRR1 CCNA2 EEF2 SND1 TCF25 WDR82 | 2.63e-05 | 971 | 249 | 20 | 33306668 | |
| Pubmed | 2.66e-05 | 49 | 249 | 5 | 18936436 | ||
| Pubmed | 2.95e-05 | 9 | 249 | 3 | 31960486 | ||
| Interaction | HDAC1 interactions | DCAF1 MYH1 MYH2 MYH4 NR2C2 AHCYL1 MYH8 ZNF219 RAPGEF6 GAPDH TRPM7 CIC FASN TAF1 PLEC DNMT1 CCNL2 DNAJC13 DRG2 NSD2 RBL2 UBR4 USP24 GCM1 ZDBF2 POLR3A ARRB2 ZFHX4 WDR6 KDM4A DCTN4 PRDM16 RAI1 | 9.37e-07 | 1108 | 238 | 33 | int:HDAC1 |
| Interaction | TRIM28 interactions | DCAF1 TPP2 NR2C2 CAND1 GAPDH DHX38 MCM5 ITGA4 CIC ZNF440 MAP3K4 DHX15 ZNF462 FASN NR0B1 GNAI3 FHL2 ZNF614 DNMT1 DRG2 NSD2 POLE UBR4 PARG RPP30 MSH3 POLR3A CCNA2 ARRB2 TIMM21 SND1 ZNF684 ZNF382 PRIM2 WDR82 SMS PRKDC DCTN4 | 4.25e-06 | 1474 | 238 | 38 | int:TRIM28 |
| GeneFamily | Myosin heavy chains | 9.06e-06 | 15 | 168 | 4 | 1098 | |
| GeneFamily | Dyneins, axonemal | 1.56e-05 | 17 | 168 | 4 | 536 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 1.56e-05 | 17 | 168 | 4 | 1059 | |
| GeneFamily | ATAC complex | 2.10e-04 | 13 | 168 | 3 | 1058 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.66e-04 | 14 | 168 | 3 | 1095 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.87e-04 | 17 | 168 | 3 | 486 | |
| GeneFamily | Chloride channel accessory | 5.09e-04 | 4 | 168 | 2 | 867 | |
| GeneFamily | Cyclins | 2.18e-03 | 28 | 168 | 3 | 473 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.32e-03 | 8 | 168 | 2 | 939 | |
| GeneFamily | Lysozymes, c-type | 2.96e-03 | 9 | 168 | 2 | 1174 | |
| GeneFamily | Fibronectin type III domain containing | 3.85e-03 | 160 | 168 | 6 | 555 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#4_top-relative-expression-ranked_500 | 4.77e-06 | 85 | 236 | 8 | gudmap_developingGonad_e16.5_testes_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | CAND1 SPON1 CCL11 FHL2 CILP ANGPTL1 CLDN11 ZFHX4 ENTPD1 OSMR PGM2 EPHA3 | 2.50e-05 | 250 | 236 | 12 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_100 | 4.20e-05 | 84 | 236 | 7 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DCAF1 MYO9A MCM5 TKTL1 SCML2 ATP11B BRDT GLDC TAF1 METTL25 PMS1 DNAJC13 POLE GRK4 PARG TRAPPC8 DENR PRIM2 CAPRIN2 SMS PRKDC FGD6 ARHGAP19 | 4.68e-05 | 820 | 236 | 23 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | DCAF1 MCM5 ZNF462 SCML2 ATP11B BRDT GLDC TAF1 METTL25 RBM47 PMS1 DNAJC13 NSD2 POLE PARG TRAPPC8 RRN3 PRIM2 CAPRIN2 SMS PRKDC FGD6 ARHGAP19 | 4.86e-05 | 822 | 236 | 23 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_500 | TKTL1 KAT2A ITGA4 DSCAML1 SCML2 CLCA1 BRDT IRF2BPL MMD2 MMD2 CCNL2 REN LHCGR ARRB2 EPHA3 | 5.77e-05 | 409 | 236 | 15 | gudmap_developingGonad_e16.5_testes_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 6.05e-05 | 38 | 236 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.82e-05 | 160 | 236 | 9 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | NR2C2 TKTL1 KAT2A ITGA4 DSCAML1 MAP3K4 HSPA12A SCML2 CLCA1 BRDT VPS35L NR0B1 IRF2BPL MMD2 PLEC MMD2 CCNL2 REN LHCGR ARRB2 TCF25 EPHA3 | 1.28e-04 | 819 | 236 | 22 | gudmap_developingGonad_e16.5_testes_1000 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | MYH2 ELAPOR2 EPHA6 PTPRQ PKHD1 DNAH9 WNK2 POLE DUOX2 ADAM2 EPHA5 | 1.96e-09 | 162 | 248 | 11 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 DSCAML1 GALNT13 SLITRK2 PTPRQ PKHD1 DMD DNAH9 ZFHX4 EPHA5 DNAH11 | 7.47e-09 | 184 | 248 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 DSCAML1 GALNT13 SLITRK2 PTPRQ PKHD1 DMD DNAH9 ZFHX4 EPHA5 DNAH11 | 7.47e-09 | 184 | 248 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 DSCAML1 GALNT13 SLITRK2 PTPRQ PKHD1 DMD DNAH9 ZFHX4 EPHA5 DNAH11 | 7.47e-09 | 184 | 248 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.28e-09 | 145 | 248 | 10 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | EXPH5 ITGA2 TC2N GLDC PKHD1 RBM47 WNK2 PPP1R14C TEC HAS3 PRDM16 | 9.88e-09 | 189 | 248 | 11 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH8 DSCAML1 GALNT13 AADACL2 PTPRQ PKHD1 DNAH9 LAMA2 ZFHX4 EPHA5 | 2.38e-08 | 160 | 248 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH8 DSCAML1 GALNT13 AADACL2 PTPRQ PKHD1 DNAH9 LAMA2 ZFHX4 EPHA5 | 2.38e-08 | 160 | 248 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | EXPH5 ITGA2 TC2N GLDC PKHD1 RBM47 PPP1R14C IL17RE HAS3 PRDM16 | 1.04e-07 | 187 | 248 | 10 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | EPHA6 EXPH5 TC2N PKHD1 DMD RBM47 PPP1R14C GPR39 RASSF9 PRDM16 | 1.27e-07 | 191 | 248 | 10 | 60ff989fe99d243a3d52955223680cdd1f1917a4 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | EPHA6 EXPH5 TC2N GLDC PKHD1 RBM47 PPP1R14C GPR39 HAS3 PRDM16 | 1.33e-07 | 192 | 248 | 10 | d3634574b2e8d2ded6446969361b70761b331aea |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | EPHA6 EXPH5 TC2N PKHD1 DMD RBM47 PPP1R14C GPR39 RASSF9 PRDM16 | 1.46e-07 | 194 | 248 | 10 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | EXPH5 TC2N PKHD1 DMD RBM47 PPP1R14C GPR39 RASSF9 HAS3 PRDM16 | 1.61e-07 | 196 | 248 | 10 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.69e-07 | 197 | 248 | 10 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | ITGA2 ABCA9 ABCA8 ADRA1B SPON1 CCL2 CCL11 LAMA2 ANGPTL1 MACF1 | 1.85e-07 | 199 | 248 | 10 | 28c1722deef3b8347371c7359be7c64b95780de3 |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | ABCA9 ABCA8 SPON1 AADACL2 FHL2 PAPPA2 CILP LAMA2 ANGPTL1 EPHA3 | 1.94e-07 | 200 | 248 | 10 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-07 | 166 | 248 | 9 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-07 | 166 | 248 | 9 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-07 | 175 | 248 | 9 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.05e-06 | 186 | 248 | 9 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ELAPOR2 GALNT13 MAST4 TC2N PIGR RBM47 PLXNA2 PPP1R14C PRDM16 | 1.05e-06 | 186 | 248 | 9 | e83718fabb057100835d3357df407f283d23fe16 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.20e-06 | 189 | 248 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.20e-06 | 189 | 248 | 9 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.20e-06 | 189 | 248 | 9 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-06 | 190 | 248 | 9 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.25e-06 | 190 | 248 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.25e-06 | 190 | 248 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-06 | 191 | 248 | 9 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | facs-Diaphragm|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-06 | 192 | 248 | 9 | 486cbf9791ca619e307e8b18aa70ce22111f4f26 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.37e-06 | 192 | 248 | 9 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.37e-06 | 192 | 248 | 9 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.37e-06 | 192 | 248 | 9 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.37e-06 | 192 | 248 | 9 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.37e-06 | 192 | 248 | 9 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.43e-06 | 193 | 248 | 9 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.43e-06 | 193 | 248 | 9 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.43e-06 | 193 | 248 | 9 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.43e-06 | 193 | 248 | 9 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.43e-06 | 193 | 248 | 9 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.49e-06 | 194 | 248 | 9 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_05-06-Epithelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.49e-06 | 194 | 248 | 9 | 47a1369c22fcbfe00b08376eb610a61c355548db | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.49e-06 | 194 | 248 | 9 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.49e-06 | 194 | 248 | 9 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.49e-06 | 194 | 248 | 9 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.55e-06 | 195 | 248 | 9 | ce1ba5911e8a6ddb07434acc37147c38e94245ff | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.55e-06 | 195 | 248 | 9 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.55e-06 | 195 | 248 | 9 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.62e-06 | 196 | 248 | 9 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.62e-06 | 196 | 248 | 9 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-06 | 197 | 248 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.76e-06 | 198 | 248 | 9 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.76e-06 | 198 | 248 | 9 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.92e-06 | 200 | 248 | 9 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.92e-06 | 200 | 248 | 9 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.92e-06 | 200 | 248 | 9 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-06 | 150 | 248 | 8 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-06 | 165 | 248 | 8 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-06 | 165 | 248 | 8 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.34e-06 | 166 | 248 | 8 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-06 | 169 | 248 | 8 | 3f738fc56bbc70dc77c9ba41025631f8264cd2b3 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.67e-06 | 176 | 248 | 8 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.95e-06 | 177 | 248 | 8 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 177 | 248 | 8 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 177 | 248 | 8 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 7.55e-06 | 179 | 248 | 8 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.19e-06 | 181 | 248 | 8 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-06 | 182 | 248 | 8 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.87e-06 | 183 | 248 | 8 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.87e-06 | 183 | 248 | 8 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.23e-06 | 184 | 248 | 8 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.23e-06 | 184 | 248 | 8 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.61e-06 | 185 | 248 | 8 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-06 | 185 | 248 | 8 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.61e-06 | 185 | 248 | 8 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.61e-06 | 185 | 248 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.99e-06 | 186 | 248 | 8 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.99e-06 | 186 | 248 | 8 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 187 | 248 | 8 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 188 | 248 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 188 | 248 | 8 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 188 | 248 | 8 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 188 | 248 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.12e-05 | 189 | 248 | 8 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 190 | 248 | 8 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 190 | 248 | 8 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 190 | 248 | 8 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 190 | 248 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 190 | 248 | 8 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 191 | 248 | 8 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 191 | 248 | 8 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 191 | 248 | 8 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 191 | 248 | 8 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 191 | 248 | 8 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 192 | 248 | 8 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 192 | 248 | 8 | 11867f30f0b420c18cb0b34d3990237aa737a0e8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 192 | 248 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 192 | 248 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 192 | 248 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-05 | 193 | 248 | 8 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.36e-05 | 194 | 248 | 8 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| Drug | Cloprostenol | 3.87e-06 | 11 | 242 | 4 | ctd:D003008 | |
| Drug | desethylamodiaquine | 5.76e-06 | 12 | 242 | 4 | ctd:C047386 | |
| Drug | azasetron | 7.13e-06 | 26 | 242 | 5 | CID000002264 | |
| Drug | carboxytolbutamide | 1.15e-05 | 14 | 242 | 4 | CID000159651 | |
| Drug | bufuralol | 1.17e-05 | 5 | 242 | 3 | ctd:C010831 | |
| Drug | wartmannin | MYH1 MYH2 MYH4 MYH8 TRPM7 MYO9A PFKFB2 ITGA2 ITGA4 F2 RPS6KC1 FASN PIGR CCL2 KDR CCL11 RAD17 FLT1 DNAJC13 HTR2B RBL2 TEC PRKDC | 2.01e-05 | 811 | 242 | 23 | CID000005691 |
| Drug | andrographolide | 2.05e-05 | 108 | 242 | 8 | ctd:C030419 | |
| Drug | 4,4'-(hexafluoroisopropylidene)diphenol | 2.05e-05 | 16 | 242 | 4 | ctd:C571725 | |
| Drug | AC1L4VPA | 2.05e-05 | 16 | 242 | 4 | CID000164901 | |
| Drug | AC1L5I84 | 2.05e-05 | 16 | 242 | 4 | CID000229851 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 2.32e-05 | 6 | 242 | 3 | ctd:C570106 | |
| Drug | avasimibe | 2.32e-05 | 6 | 242 | 3 | ctd:C423185 | |
| Drug | diniconazole | 2.32e-05 | 6 | 242 | 3 | ctd:C049346 | |
| Drug | AC1O5Z5L | 2.32e-05 | 6 | 242 | 3 | CID006443527 | |
| Drug | Cyclodextrins | 2.32e-05 | 6 | 242 | 3 | ctd:D003505 | |
| Drug | 4'-hydroxyflurbiprofen | 2.32e-05 | 6 | 242 | 3 | CID000157678 | |
| Drug | ginsenoside Rf | 2.66e-05 | 17 | 242 | 4 | CID000441922 | |
| Drug | mono-(2-ethylhexyl)phthalate | MYH8 CYP2C19 CYP2C9 GAPDH RXRG GALNT13 RYR1 FASN AFM NR0B1 PKHD1 CCL2 TAF1 DMD WNK2 DNMT1 CCNA2 LHCGR ARRB2 WDR6 | 2.72e-05 | 658 | 242 | 20 | ctd:C016599 |
| Drug | desmethylsertraline | 2.82e-05 | 34 | 242 | 5 | CID000114743 | |
| Drug | clopidogrel | 2.82e-05 | 56 | 242 | 6 | ctd:C055162 | |
| Drug | pleuromutilin | 3.39e-05 | 18 | 242 | 4 | CID000031326 | |
| Drug | purealin | 3.46e-05 | 58 | 242 | 6 | CID006419303 | |
| Drug | B0683 | 3.65e-05 | 117 | 242 | 8 | CID006398969 | |
| Drug | sulprofos | 4.02e-05 | 7 | 242 | 3 | CID000037125 | |
| Drug | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | 4.02e-05 | 7 | 242 | 3 | ctd:C547858 | |
| Drug | 16-O-demethylaconitine | 4.02e-05 | 7 | 242 | 3 | ctd:C486136 | |
| Drug | 5-fluorotryptamine | 4.02e-05 | 7 | 242 | 3 | ctd:C034536 | |
| Drug | quinidine-N-oxide | 4.02e-05 | 7 | 242 | 3 | CID000050979 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 4.02e-05 | 7 | 242 | 3 | CID005486899 | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; HL60; HG-U133A | CYP1A2 CAND1 KAT2A ITGA4 DHX15 ATP11B VPS35L SMCHD1 WDR82 ARHGAP19 | 4.76e-05 | 195 | 242 | 10 | 1582_DN |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; HL60; HG-U133A | CYP1A2 TAF12 RBM47 TADA3 DRG2 LAT2 TSPAN32 ACOT11 MACF1 WDR82 | 5.19e-05 | 197 | 242 | 10 | 2037_DN |
| Drug | N'-nitrosoanatabine | 5.28e-05 | 20 | 242 | 4 | CID000051291 | |
| Drug | ginsenoside Rc | 5.28e-05 | 20 | 242 | 4 | CID000100018 | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; HL60; HT_HG-U133A | 5.41e-05 | 198 | 242 | 10 | 2910_DN | |
| Drug | chlorzoxazone | 5.55e-05 | 63 | 242 | 6 | CID000002733 | |
| Drug | N'-nitrosonornicotine | 5.55e-05 | 63 | 242 | 6 | CID000027919 | |
| Drug | Spermine | 5.55e-05 | 63 | 242 | 6 | ctd:D013096 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 6.39e-05 | 8 | 242 | 3 | CID006439499 | |
| Drug | 5-fluoro-alpha-methyltryptamine | 6.39e-05 | 8 | 242 | 3 | ctd:C051101 | |
| Drug | 5-methyltryptamine | 6.39e-05 | 8 | 242 | 3 | ctd:C027552 | |
| Drug | AC1L4AGK | 6.39e-05 | 8 | 242 | 3 | CID000182186 | |
| Drug | 11-HODE | 6.39e-05 | 8 | 242 | 3 | CID006438497 | |
| Drug | 5-bromotryptamine | 6.39e-05 | 8 | 242 | 3 | ctd:C040997 | |
| Drug | sulforidazine | 6.39e-05 | 8 | 242 | 3 | CID000031765 | |
| Drug | lisdexamfetamine dimesylate | 6.39e-05 | 8 | 242 | 3 | CID011597697 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 6.39e-05 | 8 | 242 | 3 | ctd:C585955 | |
| Drug | ABT-761 | 6.39e-05 | 8 | 242 | 3 | CID003086671 | |
| Drug | desmethylmaprotiline | 6.39e-05 | 8 | 242 | 3 | CID000119409 | |
| Drug | germacrone | 6.39e-05 | 8 | 242 | 3 | ctd:C048393 | |
| Drug | 7-methyltryptamine | 6.39e-05 | 8 | 242 | 3 | ctd:C036696 | |
| Drug | N'-nitrosoanabasine | 7.83e-05 | 22 | 242 | 4 | CID000014335 | |
| Drug | AC1L1V2E | 7.83e-05 | 22 | 242 | 4 | CID000010376 | |
| Drug | nefazodone | 9.01e-05 | 43 | 242 | 5 | CID000004449 | |
| Drug | perazine | 9.40e-05 | 23 | 242 | 4 | CID000004744 | |
| Drug | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | 9.50e-05 | 9 | 242 | 3 | ctd:C545880 | |
| Drug | AC1L8U1Y | 9.50e-05 | 9 | 242 | 3 | CID000408120 | |
| Drug | Acenocoumarol | 9.50e-05 | 9 | 242 | 3 | ctd:D000074 | |
| Drug | 2-nitroanisole | 9.50e-05 | 9 | 242 | 3 | ctd:C005328 | |
| Drug | Tryptamines | 9.50e-05 | 9 | 242 | 3 | ctd:D014363 | |
| Drug | cis-linoleic acid | 9.50e-05 | 9 | 242 | 3 | CID006431005 | |
| Drug | 5-chlorotryptamine | 9.50e-05 | 9 | 242 | 3 | ctd:C529169 | |
| Drug | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 9.50e-05 | 9 | 242 | 3 | ctd:C109602 | |
| Drug | phenylcyclopropane | 9.50e-05 | 9 | 242 | 3 | CID000070112 | |
| Drug | S-(-)-Etomoxir | 9.72e-05 | 100 | 242 | 7 | CID000060765 | |
| Drug | Aroclor 1254 | CYP1A2 CYP2C19 CYP2C9 GAPDH RYR1 UBE2V1 PLEC GSTM4 LHCGR HAS3 | 9.95e-05 | 213 | 242 | 10 | CID000040470 |
| Drug | isoproterenol | MYH1 MYH2 MYH4 MYH8 MYO9A EXPH5 F2 RYR1 ADRA1B CLCA1 CCL2 DMD GRK4 DUOX2 REN ODC1 CLCA3P CD38 ADAT1 | 1.06e-04 | 669 | 242 | 19 | CID000003779 |
| Drug | NSC308876 | 1.12e-04 | 24 | 242 | 4 | CID000432447 | |
| Drug | dibenzylfluorescein | 1.13e-04 | 2 | 242 | 2 | ctd:C558664 | |
| Drug | 3-(5-methyl-2-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid | 1.13e-04 | 2 | 242 | 2 | ctd:C477639 | |
| Drug | 4-amino-2-phenoxymethanesulfonanilide | 1.13e-04 | 2 | 242 | 2 | ctd:C108971 | |
| Drug | dihydromethysticin | 1.25e-04 | 46 | 242 | 5 | CID000088308 | |
| Drug | metoprolol | 1.32e-04 | 105 | 242 | 7 | CID000004171 | |
| Drug | Superoxides | 1.32e-04 | 105 | 242 | 7 | ctd:D013481 | |
| Drug | guanfacine | 1.32e-04 | 25 | 242 | 4 | CID000003519 | |
| Drug | AC1L44DC | 1.32e-04 | 25 | 242 | 4 | CID000150456 | |
| Drug | N-nitrosopiperidine | 1.32e-04 | 25 | 242 | 4 | CID000007526 | |
| Drug | clofibrate | CYP1A2 CYP2C19 CYP2C9 BCKDHB RXRG CCL2 SLC25A29 PLEC AASDH GSTM4 ACOT11 HAS3 | 1.33e-04 | 311 | 242 | 12 | CID000002796 |
| Drug | Celsior | 1.35e-04 | 10 | 242 | 3 | ctd:C088453 | |
| Drug | sulconazole | 1.35e-04 | 10 | 242 | 3 | CID000005318 | |
| Drug | 3-hydroxyflunitrazepam | 1.35e-04 | 10 | 242 | 3 | CID000128908 | |
| Drug | 8-hydroxydaidzein | 1.35e-04 | 10 | 242 | 3 | CID005466139 | |
| Drug | 9 -fluorohydrocortisone acetate | 1.35e-04 | 10 | 242 | 3 | CID000003370 | |
| Drug | 13-hydroxyellipticine | 1.35e-04 | 10 | 242 | 3 | ctd:C517215 | |
| Drug | AHMA | 1.35e-04 | 10 | 242 | 3 | CID000216240 | |
| Drug | chlorobenzene | 1.37e-04 | 74 | 242 | 6 | CID000007964 | |
| Drug | norfluoxetine | 1.39e-04 | 47 | 242 | 5 | CID000004541 | |
| Drug | AC1Q6S3S | 1.43e-04 | 142 | 242 | 8 | CID000001151 | |
| Drug | 2cgu | 1.54e-04 | 48 | 242 | 5 | CID003506204 | |
| Drug | tegaserod | 1.55e-04 | 26 | 242 | 4 | CID005487301 | |
| Drug | Kn 04 | 1.55e-04 | 26 | 242 | 4 | CID000131117 | |
| Drug | 1,4-naphthoquinone | 1.55e-04 | 26 | 242 | 4 | ctd:C035342 | |
| Drug | NSC9700 | CYP1A2 MYH1 MYH2 MYH4 NR2C2 MYH8 CYP2C19 CYP2C9 RXRG NR0B1 REN ODC1 LHCGR CLDN11 PEBP1 HAS3 PSPC1 | 1.63e-04 | 578 | 242 | 17 | CID000005408 |
| Drug | Ritonavir | 1.67e-04 | 109 | 242 | 7 | ctd:D019438 | |
| Drug | oroxylin A | 1.80e-04 | 27 | 242 | 4 | CID005320315 | |
| Drug | 8-hydroxycarteolol | 1.84e-04 | 11 | 242 | 3 | CID000124688 | |
| Drug | Haloperidol metabolite I | 1.84e-04 | 11 | 242 | 3 | CID000038282 | |
| Drug | AC1L2H09 | 1.84e-04 | 11 | 242 | 3 | CID000020797 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 1.84e-04 | 11 | 242 | 3 | ctd:C507866 | |
| Drug | trifluoperazine | MYH1 MYH2 MYH4 MYH8 MYO9A F2 ADRA1B HTR2B PPP1R14C REN ODC1 EEF2 | 1.95e-04 | 324 | 242 | 12 | CID000005566 |
| Drug | formycin triphosphate | 2.05e-04 | 51 | 242 | 5 | CID000122274 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 8.20e-07 | 10 | 237 | 4 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 8.20e-07 | 10 | 237 | 4 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 8.20e-07 | 10 | 237 | 4 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 8.20e-07 | 10 | 237 | 4 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 8.20e-07 | 10 | 237 | 4 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 8.20e-07 | 10 | 237 | 4 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 8.20e-07 | 10 | 237 | 4 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 8.20e-07 | 10 | 237 | 4 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | GAPDH RPS6KC1 FASN ALDH18A1 UCK2 KDR FLT1 MSH3 PRKDC EPHA3 EPHA5 | 9.76e-07 | 206 | 237 | 11 | C0152013 |
| Disease | distal myopathy (implicated_via_orthology) | 1.91e-06 | 12 | 237 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.91e-06 | 12 | 237 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.74e-06 | 13 | 237 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.17e-06 | 15 | 237 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | right ventricular systolic volume measurement | 8.55e-06 | 35 | 237 | 5 | EFO_0021815 | |
| Disease | response to fluoropyrimidines | 6.42e-05 | 2 | 237 | 2 | EFO_0010825 | |
| Disease | Ritscher-Schinzel syndrome (is_implicated_in) | 6.42e-05 | 2 | 237 | 2 | DOID:0060565 (is_implicated_in) | |
| Disease | Intellectual Disability | RALGAPA1 CIC ZNF462 FASN TAF1 MAP7D3 NSD2 ODC1 CERT1 CCNA2 ENTPD1 MACF1 RAI1 | 7.42e-05 | 447 | 237 | 13 | C3714756 |
| Disease | Crohn's disease (is_marker_for) | 8.23e-05 | 29 | 237 | 4 | DOID:8778 (is_marker_for) | |
| Disease | macular retinal edema (is_marker_for) | 1.07e-04 | 12 | 237 | 3 | DOID:4449 (is_marker_for) | |
| Disease | Squamous cell carcinoma of lung | 1.22e-04 | 32 | 237 | 4 | C0149782 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.35e-04 | 97 | 237 | 6 | DOID:3083 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | DPYSL5 DSCAML1 ZNF462 MAST4 PLEC WNK2 SMG6 SND1 MACF1 HAS3 PRDM16 FGD6 EPHA3 DNAH11 | 1.60e-04 | 550 | 237 | 14 | EFO_0004346, EFO_0004464 |
| Disease | birth weight, parental genotype effect measurement | 1.71e-04 | 192 | 237 | 8 | EFO_0004344, EFO_0005939 | |
| Disease | Liver Cirrhosis | 1.88e-04 | 103 | 237 | 6 | C0023890 | |
| Disease | Hypermetropia | 1.88e-04 | 103 | 237 | 6 | HP_0000540 | |
| Disease | cyclo(leu-pro) measurement | 1.92e-04 | 3 | 237 | 2 | EFO_0800676 | |
| Disease | X-21258 measurement | 1.92e-04 | 3 | 237 | 2 | EFO_0800802 | |
| Disease | cerebral cavernous malformation (is_marker_for) | 1.92e-04 | 3 | 237 | 2 | DOID:0060669 (is_marker_for) | |
| Disease | allergic contact dermatitis (is_marker_for) | 1.92e-04 | 3 | 237 | 2 | DOID:3042 (is_marker_for) | |
| Disease | arteriovenous malformations of the brain (is_marker_for) | 1.92e-04 | 3 | 237 | 2 | DOID:0060688 (is_marker_for) | |
| Disease | Fibrosis, Liver | 2.09e-04 | 105 | 237 | 6 | C0239946 | |
| Disease | coronary artery disease | DAB2IP CYP1A2 TRPM7 DHX38 KAT2A ABCA8 GALNT13 MAST4 ATXN2 PKHD1 RBM47 WNK2 SMG6 FLT1 DNAJC13 MAP7D3 DUOX2 CERT1 PRIM2 PRDM16 FGD6 RAI1 | 2.74e-04 | 1194 | 237 | 22 | EFO_0001645 |
| Disease | Endometrial Carcinoma | 2.89e-04 | 72 | 237 | 5 | C0476089 | |
| Disease | ulcerative colitis (is_marker_for) | 2.96e-04 | 40 | 237 | 4 | DOID:8577 (is_marker_for) | |
| Disease | oral squamous cell carcinoma (biomarker_via_orthology) | 3.81e-04 | 4 | 237 | 2 | DOID:0050866 (biomarker_via_orthology) | |
| Disease | Clozapine response | 3.81e-04 | 4 | 237 | 2 | cv:CN077971 | |
| Disease | tyrosine-protein kinase TEC measurement | 3.81e-04 | 4 | 237 | 2 | EFO_0020830 | |
| Disease | neuroimaging measurement | CYP1A2 DPYSL5 PFKFB2 ZNF462 NEUROD2 MAST4 ATXN2 PKHD1 PLEC PLXNA2 WNK2 SMG6 LAMA2 SND1 MACF1 PRDM16 FGD6 RAI1 EPHA3 DNAH11 | 4.30e-04 | 1069 | 237 | 20 | EFO_0004346 |
| Disease | cystathionine measurement | 4.51e-04 | 19 | 237 | 3 | EFO_0010474 | |
| Disease | toxic shock syndrome (is_marker_for) | 4.51e-04 | 19 | 237 | 3 | DOID:14115 (is_marker_for) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.72e-04 | 80 | 237 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 4.97e-04 | 225 | 237 | 8 | EFO_0008317, EFO_0020947 | |
| Disease | Hemorrhage | 5.27e-04 | 20 | 237 | 3 | C0019080 | |
| Disease | Cardiomegaly | 5.29e-04 | 82 | 237 | 5 | C0018800 | |
| Disease | Cardiac Hypertrophy | 5.29e-04 | 82 | 237 | 5 | C1383860 | |
| Disease | Drug toxicity | 5.91e-04 | 84 | 237 | 5 | C0013221 | |
| Disease | Adverse reaction to drug | 5.91e-04 | 84 | 237 | 5 | C0041755 | |
| Disease | myopathy (implicated_via_orthology) | 5.98e-04 | 48 | 237 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Deep Vein Thrombosis | 6.11e-04 | 21 | 237 | 3 | C0149871 | |
| Disease | Venous Thrombosis | 6.11e-04 | 21 | 237 | 3 | C0042487 | |
| Disease | Nephritis, Tubulointerstitial | 6.11e-04 | 21 | 237 | 3 | C0041349 | |
| Disease | Duchenne and Becker Muscular Dystrophy | 6.32e-04 | 5 | 237 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 6.32e-04 | 5 | 237 | 2 | C0917713 | |
| Disease | Nephritis, Interstitial | 9.14e-04 | 24 | 237 | 3 | C0027707 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.31e-04 | 139 | 237 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | glucagon measurement, glucose tolerance test | 9.43e-04 | 6 | 237 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | portal hypertension (is_marker_for) | 9.43e-04 | 6 | 237 | 2 | DOID:10762 (is_marker_for) | |
| Disease | extraversion measurement | 9.43e-04 | 6 | 237 | 2 | EFO_0007913 | |
| Disease | Muscular Dystrophy, Duchenne | 9.43e-04 | 6 | 237 | 2 | C0013264 | |
| Disease | creatinine measurement | CYP1A2 CAND1 DPYSL5 PFKFB2 RYR1 SLC9B1 LARP4B KAT2B PKHD1 SLC25A29 PLEC RBM47 SLC23A1 DNAJC13 LAMA2 CCNA2 RGS14 SND1 | 1.21e-03 | 995 | 237 | 18 | EFO_0004518 |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 1.31e-03 | 7 | 237 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | retinal vein occlusion (is_implicated_in) | 1.31e-03 | 7 | 237 | 2 | DOID:1727 (is_implicated_in) | |
| Disease | vascular cell adhesion protein 1 measurement | 1.31e-03 | 7 | 237 | 2 | EFO_0020846 | |
| Disease | brain connectivity measurement | 1.57e-03 | 400 | 237 | 10 | EFO_0005210 | |
| Disease | Drug-Induced Liver Disease | CYP1A2 CYP2C19 CYP2C9 FASN CCL2 SLC25A29 FLT1 GRK4 GSTM4 PRKDC | 1.69e-03 | 404 | 237 | 10 | C0860207 |
| Disease | Drug-Induced Acute Liver Injury | CYP1A2 CYP2C19 CYP2C9 FASN CCL2 SLC25A29 FLT1 GRK4 GSTM4 PRKDC | 1.69e-03 | 404 | 237 | 10 | C3658290 |
| Disease | Hepatitis, Toxic | CYP1A2 CYP2C19 CYP2C9 FASN CCL2 SLC25A29 FLT1 GRK4 GSTM4 PRKDC | 1.69e-03 | 404 | 237 | 10 | C0019193 |
| Disease | Chemically-Induced Liver Toxicity | CYP1A2 CYP2C19 CYP2C9 FASN CCL2 SLC25A29 FLT1 GRK4 GSTM4 PRKDC | 1.69e-03 | 404 | 237 | 10 | C4279912 |
| Disease | Chemical and Drug Induced Liver Injury | CYP1A2 CYP2C19 CYP2C9 FASN CCL2 SLC25A29 FLT1 GRK4 GSTM4 PRKDC | 1.69e-03 | 404 | 237 | 10 | C4277682 |
| Disease | Hepatitis, Drug-Induced | CYP1A2 CYP2C19 CYP2C9 FASN CCL2 SLC25A29 FLT1 GRK4 GSTM4 PRKDC | 1.69e-03 | 404 | 237 | 10 | C1262760 |
| Disease | Muscular Dystrophy | 1.74e-03 | 8 | 237 | 2 | C0026850 | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 1.74e-03 | 8 | 237 | 2 | DOID:14320 (implicated_via_orthology) | |
| Disease | tumor necrosis factor receptor II measurement | 1.74e-03 | 8 | 237 | 2 | EFO_0008384 | |
| Disease | Colorectal Neoplasms | 1.89e-03 | 277 | 237 | 8 | C0009404 | |
| Disease | Congestive heart failure | 1.98e-03 | 110 | 237 | 5 | C0018802 | |
| Disease | Heart failure | 1.98e-03 | 110 | 237 | 5 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.98e-03 | 110 | 237 | 5 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.98e-03 | 110 | 237 | 5 | C0235527 | |
| Disease | Heart Decompensation | 1.98e-03 | 110 | 237 | 5 | C1961112 | |
| Disease | Myocardial Failure | 1.98e-03 | 110 | 237 | 5 | C1959583 | |
| Disease | red blood cell density measurement | RALGAPA1 ZNF219 MYO9A ZNF462 LARP4B KAT2B ADRA1B NEUROD2 CEP78 ATXN2 PKHD1 PLEC SMG6 TSPAN32 RGS14 KDM4A | 2.14e-03 | 880 | 237 | 16 | EFO_0007978 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.20e-03 | 222 | 237 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | phospholipids:total lipids ratio | 2.49e-03 | 227 | 237 | 7 | EFO_0020946 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.51e-03 | 169 | 237 | 6 | DOID:3908 (is_marker_for) | |
| Disease | migraine disorder | 2.52e-03 | 357 | 237 | 9 | MONDO_0005277 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.59e-03 | 71 | 237 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.59e-03 | 71 | 237 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.69e-03 | 118 | 237 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | hyperglycemia (is_implicated_in) | 2.77e-03 | 10 | 237 | 2 | DOID:4195 (is_implicated_in) | |
| Disease | theophylline measurement | 2.77e-03 | 10 | 237 | 2 | EFO_0021180 | |
| Disease | alopecia areata (is_marker_for) | 2.77e-03 | 10 | 237 | 2 | DOID:986 (is_marker_for) | |
| Disease | 1,7-dimethylurate measurement | 2.77e-03 | 10 | 237 | 2 | EFO_0021512 | |
| Disease | threonate measurement | 2.77e-03 | 10 | 237 | 2 | EFO_0021032 | |
| Disease | Immature Reticulocyte Fraction Measurement | 2.77e-03 | 10 | 237 | 2 | EFO_0009253 | |
| Disease | pneumonia (implicated_via_orthology) | 2.77e-03 | 10 | 237 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | endometrial cancer (is_implicated_in) | 3.00e-03 | 36 | 237 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.32e-03 | 239 | 237 | 7 | EFO_0008317, EFO_0020945 | |
| Disease | X-11308 measurement | 3.37e-03 | 11 | 237 | 2 | EFO_0800693 | |
| Disease | 1-methylxanthine measurement | 3.37e-03 | 11 | 237 | 2 | EFO_0021174 | |
| Disease | angina pectoris | 3.44e-03 | 125 | 237 | 5 | EFO_0003913 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVCPRYTAVLARSED | 21 | O75528 | |
| QASRKYSEFTLKCPI | 16 | Q9BZS9 | |
| KRVTVLKYFLEALCG | 1126 | Q86US8 | |
| FKLTPVAYGCKVETI | 421 | O60825 | |
| LCAISVDRYIAIKKP | 146 | P41595 | |
| KILTKYGVDPTRICI | 171 | Q6P093 | |
| YRIGRIKEIFCPKKS | 991 | P26358 | |
| ELEKYVSACLRKRPL | 566 | Q58F21 | |
| RRPCFESLKADKTYV | 506 | P43652 | |
| ICKYVGKFLLQIPRA | 546 | Q99965 | |
| KRSGYCKTRLEIGFP | 116 | Q9H8M1 | |
| PVIIASCLRKEYAGK | 1281 | Q8IUA7 | |
| IALVSVRVYYKKCPS | 221 | P54756 | |
| SRILPSDACKIYKQG | 241 | Q8N6S4 | |
| VYRPLKHTLVTCDKG | 261 | Q14094 | |
| KAGRKAVSCTPLYVE | 36 | Q4W4Y0 | |
| DKYVPACLDKLRTSF | 2351 | Q96DT5 | |
| CKIRVFPEIDKTVRY | 146 | Q6P1R4 | |
| DRKYIVSCKQTEVPL | 361 | Q8WXI4 | |
| IIYPCSSKEFKRAFV | 346 | P35368 | |
| SAYRLQSECKKTLPG | 706 | Q14161 | |
| YRIPEKTLNSTLKCE | 356 | Q4L235 | |
| AKKCAYTFLVPEQRI | 46 | O95841 | |
| VLVRKPEGAICLYTK | 646 | O60423 | |
| VPAIRYKDVTFQLCK | 96 | Q5JTW2 | |
| CKECPIIGFRYRSLK | 3316 | P11532 | |
| TRPGKCFRLYTEKAY | 476 | O43143 | |
| SFRVYCIILVKPKDV | 66 | Q96EU7 | |
| PDYLKDRKVFVTLTC | 46 | P32121 | |
| AKVIDVYRTGAKCVP | 251 | Q9BUB4 | |
| TKRFPETVLARCVKY | 56 | P28907 | |
| EKRFLLGKPSDYCII | 66 | O75901 | |
| AEPEIRLKYISSCKR | 1571 | Q7Z5J4 | |
| PGCVERVKKIRDYAF | 271 | A0AV96 | |
| PSNCAASTEKIYIRK | 201 | P49116 | |
| DAKSTLRVLYGLFCK | 301 | Q9HBI0 | |
| IYGLSTKRIACLLEK | 601 | Q99650 | |
| LFRALGKILYCKRAS | 396 | O75943 | |
| TRDTTLNGFYIPKKC | 391 | P05177 | |
| EKREAKPVSCRAAYR | 71 | Q6ZSG2 | |
| IRKVYPGLSCFKEGV | 686 | Q92830 | |
| EDYYRCKITPSARKP | 196 | Q9UND3 | |
| LYVACRKSVPTVSKG | 91 | Q08999 | |
| ASVLRAVAKREYPKF | 591 | Q9Y5P4 | |
| GPEKVKKLCNSTYRR | 66 | Q5VTT2 | |
| RDKYGKDRVFNTPLC | 111 | P21953 | |
| KIINSYCVFPRELKE | 481 | Q5VWQ8 | |
| SLAKVAKQGDYCRPT | 836 | P20585 | |
| CKYAAELIERVSGKP | 806 | Q9Y4B6 | |
| EALRYCKVGSYLKSP | 261 | Q9H8M7 | |
| KAGTACLPARYKLVE | 171 | Q8IY49 | |
| PVEICKGKQLYTIAR | 736 | A4D1F6 | |
| CRPSVYSLSYIKRGK | 6 | Q9UMX2 | |
| FRYKAVSGPCQVKLL | 141 | O43194 | |
| KYLSICNTGIRKFPD | 126 | P22888 | |
| IYTRCKLAKIFSRAG | 21 | Q6UWQ5 | |
| IYTRCKLAKIFSRAG | 21 | Q7Z4W2 | |
| EKIKRSPLTICYPEY | 276 | P08754 | |
| IRKVYPGLSCFKDGV | 681 | Q92831 | |
| KFIAYCRVKCGPRLS | 561 | P33992 | |
| TARITCSGDALPKKY | 36 | A0A075B6K4 | |
| KKLALASRFYIPEGC | 891 | Q96S38 | |
| EGVFKTYSPKCDLVL | 291 | Q99700 | |
| LVKLFDPVKSPRCYA | 581 | Q8N6Q8 | |
| DPVKSPRCYAVIALK | 586 | Q8N6Q8 | |
| SITLDIRFPPCCYKK | 516 | Q5U5R9 | |
| ASYLQEDTVRRKKCP | 246 | Q8NFR9 | |
| RKPSYAEICQRTSKE | 646 | Q92615 | |
| RGCRTLLLKIPKEYD | 701 | Q9NRD8 | |
| ATPYIKDLFTCTIKR | 561 | Q86VP6 | |
| NRGEVKYPLCTRKES | 506 | P05160 | |
| TLAGCTPYEVRFKKD | 381 | Q9H1B7 | |
| ADLLKALCYPRVKVG | 396 | P13535 | |
| YTSRIVRLCKDDPKF | 276 | O75051 | |
| PLVYGAKTKEICSRV | 301 | Q8NGF3 | |
| CYFRRVTEKKPTGLV | 681 | Q86W56 | |
| ADLLKALCYPRVKVG | 396 | Q9UKX2 | |
| CRKGFPSRILYADFK | 711 | Q9UKX2 | |
| VASFRKKYELRAPVA | 151 | P30086 | |
| EACVKKYPLTVFESR | 741 | O96028 | |
| LPCEVSTYAKSRKDI | 251 | P23743 | |
| YVCPLYKTSERKGTL | 3041 | Q6ZR08 | |
| YPKACGKFEISAIRD | 506 | Q96G03 | |
| EFRKIANSDKYCTPR | 96 | O75164 | |
| SVLFEYFVCRKPKIR | 396 | P0C6S8 | |
| KVSELDTIYCTLPRK | 1011 | Q8NEV8 | |
| VCTTKKTFDPYIIIR | 101 | Q13601 | |
| KYSGCLKDIEISRTP | 2491 | P24043 | |
| ADLLKALCYPRVKVG | 396 | P12882 | |
| DAGLSCRYIISRKPE | 1071 | Q07864 | |
| ALEPEAASIYCRKLR | 236 | O43301 | |
| ECKLVSFPIGIYKVL | 31 | Q8TCA0 | |
| EDYYRCKITPSARKP | 196 | F8WFD2 | |
| FRGSSYPVCVSKVVK | 46 | P00973 | |
| VNVSDLYKTPCTKRF | 291 | P49961 | |
| KVRKYISVDAPCLGL | 156 | Q5TGP6 | |
| QKSVACDVGYPALKR | 871 | P17301 | |
| PRNTYSEKGAKECIR | 311 | A8MWY0 | |
| IRTCKPAFLSEEKLY | 2991 | Q9UPN3 | |
| LVSDGSSRPYRCKIK | 411 | O75306 | |
| KVTRLVRDSKCEYPA | 596 | P54886 | |
| GRIISYIVKYKEVCP | 126 | Q9UMZ3 | |
| SLPDVRLEGCKTKVY | 96 | Q8IUC8 | |
| GLLKTLRFVKYLPCF | 261 | P51843 | |
| EGKRTDYTPFSCLKI | 356 | P49643 | |
| SSVTAAPRARKYKCG | 46 | P98173 | |
| ERKTSIVDCGIYTPK | 1171 | Q9BXP8 | |
| KCLEAYLESKRVIFP | 1176 | Q9C0G6 | |
| KSLKLVRYRAFCSPS | 6 | Q7L8L6 | |
| TCDVKFRNYLIPKGT | 371 | P33261 | |
| YRRITSSKCPKEAVI | 51 | P13500 | |
| KPNGVIRKYTIFCSS | 1216 | Q8TD84 | |
| SEIRGSRKSKDCKYP | 441 | Q96S94 | |
| YTIPTCRKLDELGSK | 36 | O75508 | |
| GRKIYLRPAICDKAR | 91 | Q9NP62 | |
| PCLVTGYTDAKRTRV | 216 | Q8IX06 | |
| LYRKGVIKATPTTCD | 271 | P56202 | |
| ALVSVRVYFKKCPFT | 191 | P29320 | |
| LDYLIKFSKLTCPER | 251 | Q6IMN6 | |
| GKKYILREESPYCVV | 16 | Q14192 | |
| IKDLCRVLYFGKSIP | 1501 | O75165 | |
| KPQYRGTLHCFKSII | 36 | Q8N8R3 | |
| ACTPKERDFVYGKLE | 326 | Q9UH90 | |
| IPIAKKRLSSYTECY | 481 | Q8IWC1 | |
| SEYKLEGRSVSCLKP | 1786 | O15021 | |
| IDLTLCFSYKGKEVP | 496 | P13612 | |
| PRAKKKYVTRVCGLA | 121 | O43583 | |
| YLAIIARRCGKKPEQ | 531 | O00219 | |
| ACIPIKKSDPVVSYR | 566 | P13639 | |
| DPCIYRVSVRKELKG | 76 | Q5T8I3 | |
| YLPTCLDTLRTRFKK | 2321 | Q9NYC9 | |
| TCDIKFRNYLIPKGT | 371 | P11712 | |
| LIRKTGYTLESLKPC | 376 | P20248 | |
| KDYSSLCDKQPIGRR | 51 | P32298 | |
| VCKPKYSGTLNLDRV | 1991 | P49327 | |
| RAKPKVYIIQACRGE | 121 | P31944 | |
| GEKKVRAPLSQLYFC | 16 | Q9UJW0 | |
| VYPARVCDAVKALKA | 101 | Q9Y315 | |
| GYNCLKVPLVIFKRE | 4661 | P21817 | |
| NLKCLKESTRLYPVF | 281 | P54277 | |
| LKALPRVTPFYAVKC | 56 | P11926 | |
| RLEKYPDEKSVCLRG | 41 | Q8TEW6 | |
| RPANSERYVVCKGLK | 436 | Q8N1G2 | |
| FCPLRSFPDTVYKKL | 461 | Q9BPU6 | |
| CYKPTEEFIKELLSR | 136 | Q8TAE6 | |
| ALVSVRVFYKKCPFT | 196 | Q9UF33 | |
| STFLTKRLPYCKGNV | 161 | Q8NH53 | |
| EDYYRCKITPSARKP | 196 | E9PJI5 | |
| EDYYRCKITPSARKP | 196 | P0DM63 | |
| PRACYTLEFKAGKLA | 206 | O14926 | |
| CLTSIYRPFVDKALK | 521 | Q9Y6R4 | |
| VRCSRPGAKRSEKIY | 26 | Q9GZY6 | |
| CITVTEKLPFYFKRP | 126 | P78346 | |
| KFPFVRKSERTLECY | 211 | Q9NYV6 | |
| CIPVLKRYAKEGREF | 256 | P52788 | |
| KVPKSEGYCSRILRA | 36 | Q9HCB6 | |
| TKRVCLVGKSRTYPS | 496 | Q8IYL2 | |
| FVKVYPSCRGGKVVL | 116 | Q9NX07 | |
| IYCFPGVRKTALAIK | 591 | P0C7P3 | |
| GLIVYCVTSPKKDDR | 1486 | Q8TEU7 | |
| KKRGLAPIECYNRIS | 496 | A6NHR9 | |
| LLVQYSAKGPCVERK | 61 | O75324 | |
| VCKAGISREKVVPLY | 66 | Q99942 | |
| PRSEVKRLYGSVCDL | 146 | Q8N9U0 | |
| PGCEKYNLFESSIRK | 141 | P42680 | |
| EDYYRCKITPSARKP | 196 | E9PKD4 | |
| RLYQLSKAGKLCVPA | 261 | O43865 | |
| FGSEEIRPYKKACTT | 131 | Q16514 | |
| GKEYVRCETVRKPAV | 1176 | P21675 | |
| KRLFDYVVKCNEGPT | 316 | P00797 | |
| SVVDLTCRLEKPAKY | 241 | P04406 | |
| LARVCYSPDFEKLKP | 111 | Q03013 | |
| DPILRKGKERYTCRY | 941 | Q9HAZ2 | |
| YFPSRDQDKLVCKRT | 326 | Q86UD5 | |
| YSICTSKLRVKPGDV | 1151 | O14802 | |
| DRINKTVLYGTPRKC | 796 | Q9H156 | |
| SGSRLKLYLPKETCL | 536 | Q7KZF4 | |
| ADLLKSLCYPRVKVG | 396 | Q9Y623 | |
| GSCIFIYIKPSAKEE | 251 | A6NDL8 | |
| CASPRKYLFKDLDGR | 3346 | P08F94 | |
| CIYTKKRGQRPDFTD | 291 | P55039 | |
| IPRKDTGLYYRKCQL | 266 | Q7L1T6 | |
| RTCYARLPFLKILEK | 101 | Q7Z7B1 | |
| EKPVIIASCLRKEYA | 1276 | O94911 | |
| VKKSFLVYRNDCSLP | 981 | P55201 | |
| SRLQSPKVCGYLKVD | 176 | P78536 | |
| LESYRRITSGKCPQK | 46 | P51671 | |
| RYADIFPSKVCLQLK | 1496 | Q96RK0 | |
| FRACYIKVKIVGPLE | 951 | O75339 | |
| SKGSCPLRKYIIVNS | 556 | Q8N1N0 | |
| CSGLRSAFTVIRKKY | 386 | A8K7I4 | |
| TGLYEAKCTFIPKRS | 216 | Q9Y6N3 | |
| ALKGLRTLCIAYRKF | 621 | Q9Y2G3 | |
| ETCDLGKIKPEARRY | 151 | Q9BYT8 | |
| LRKTKLPEYTREALC | 91 | Q3KNT9 | |
| VDVCLKKGDFSLYPT | 861 | Q9NRJ4 | |
| TGEKLYECKQRSVVP | 481 | Q8IYI8 | |
| YRNLISVGCPITKTK | 41 | Q5T5D7 | |
| LKVLKACFSDYRTPT | 2896 | Q86UP3 | |
| IPRFYVEASILKCNK | 291 | Q7Z3J2 | |
| VLYDCQEGKPKRTLY | 46 | Q6UXN9 | |
| LDKFLDPARPYKCTV | 1181 | Q9C0A1 | |
| IYCTKEPFIKARVIV | 291 | Q6GYQ0 | |
| SFTEYIRKICLPEAK | 281 | Q86T26 | |
| PKFLAYSRDTACAKT | 561 | A0A1B0GUW6 | |
| GIVKRITFLKYIPIC | 551 | Q9UHI7 | |
| LKPGEKTYTQRCRLF | 71 | Q8WXF1 | |
| KPAKVGFQCYDRTLS | 46 | Q6T4P5 | |
| DCALETKTVFGYLKP | 401 | Q9UQR0 | |
| RSLKVYIKTVTCYPE | 431 | P58005 | |
| YIKTVTCYPERTTKR | 436 | P58005 | |
| GCSLDRKGKYTLTPR | 226 | Q96QS1 | |
| AIEEYAKKRITFCPS | 1181 | Q6ZV73 | |
| LPKKETGAASFLCRY | 16 | P29144 | |
| ENRIYSLKIECGPKY | 61 | Q13404 | |
| EKPYTCEERGKVFSR | 266 | A6NP11 | |
| RKKDYIILGEPSCQS | 1606 | Q9HCK1 | |
| GFFKRTIRKDLIYTC | 161 | P48443 | |
| IDSGYCKLKVFNPRI | 821 | Q92620 | |
| FYSPREVKVVAKGFC | 206 | Q15166 | |
| ICEKRGLSLPDIKVY | 331 | O43566 | |
| KLFKAPAYIRECARL | 306 | Q14CB8 | |
| KKETYISCPLRGVLN | 51 | Q4ZJI4 | |
| LDVLEKYRGKCEPTF | 71 | Q86XW9 | |
| FCLPTKKYADVIIPR | 196 | Q9BZX2 | |
| KLRDVGAYSKYLTCP | 4561 | Q15149 | |
| SVAVLCPYNRKESKS | 366 | P01833 | |
| PSGKAIFVKERCRYL | 471 | Q9NNW5 | |
| DPFVKAAKVESYRCR | 41 | Q9UI43 | |
| KDCLSIPYRLIFEKF | 2246 | P78527 | |
| AFLKSLGCDRPINYK | 211 | Q8N4Q0 | |
| SSPSKIYGRALEKCR | 136 | Q9BVV7 | |
| SIPYKREESLGKCLL | 141 | Q9UPU5 | |
| SVSRECYKKILEINP | 191 | Q9H892 | |
| VVPIEVCRSKLSKYL | 2281 | Q96JM2 | |
| RKAYVEFVNVSKCPL | 931 | Q9Y2L5 | |
| KYTACETARTPRDKL | 86 | P00734 | |
| YPGVKIDEEFCRRLK | 1106 | P35968 | |
| KGYCTPLVRKIRSDL | 776 | O43314 | |
| YRKVTCGIKPASFEK | 406 | Q9Y3S1 | |
| DKICIPNEYRKGSTV | 256 | Q8N883 | |
| KGLYTCRVRSGPSFK | 306 | P17948 | |
| NRISKTILCEYKPDG | 126 | Q96SR6 | |
| PFCYIKLSSIKVDTR | 3541 | Q5T4S7 | |
| CREGYKFQPTKVLGI | 4841 | Q5T4S7 | |
| KRGCPRTALEYCKLI | 356 | Q9BQ70 | |
| PDYRVGDKIATRKAC | 281 | P51854 | |
| LTKRECVYIIPSSKD | 11 | Q96QT4 | |
| PYCKGKFRTSAERER | 166 | Q9P2Y4 | |
| RAKYTGVLTELKLPC | 236 | P23378 | |
| LEDRCYPVSKRKLIE | 11 | Q9P2K6 | |
| VDVLYSRVCKPKRRD | 196 | Q9H400 | |
| YFVKCIRSNAEKLPL | 911 | B2RTY4 | |
| KRPDLVSYVQTLCKG | 181 | Q15784 |